[HTML][HTML] NF-κB inhibitors in treatment and prevention of lung cancer

RR Rasmi, KM Sakthivel… - Biomedicine & …, 2020 - Elsevier
Intracellular signalling pathways have provided excellent resource for drug development
particularly in the development of cancer therapeutics. A wide variety of malignancies …

HSP90 mediates the connection of multiple programmed cell death in diseases

C Peng, F Zhao, H Li, L Li, Y Yang, F Liu - Cell death & disease, 2022 - nature.com
Abstract Heat shock protein (HSP) 90, an important component of the molecular chaperone
network, is closely concerned with cellular signaling pathways and stress response by …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …

Tumor necrosis factor and cancer, buddies or foes?1

X Wang, Y Lin - Acta Pharmacologica Sinica, 2008 - Wiley Online Library
Tumor necrosis factor (TNF) is a multifunctional cytokine that plays important roles in diverse
cellular events such as cell survival, proliferation, differentiation, and death. As a pro …

IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis

JE Vince, WWL Wong, N Khan, R Feltham, D Chau… - Cell, 2007 - cell.com
XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be
relieved by IAP antagonists, such as Smac/DIABLO. IAP antagonist compounds (IACs) have …

The TRAIL apoptotic pathway in cancer onset, progression and therapy

RW Johnstone, AJ Frew, MJ Smyth - Nature Reviews Cancer, 2008 - nature.com
Triggering of tumour cell apoptosis is the foundation of many cancer therapies. Death
receptors of the tumour necrosis factor (TNF) superfamily have been largely characterized …

The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy

Y Lin, L Bai, W Chen, S Xu - Expert opinion on therapeutic targets, 2010 - Taylor & Francis
Importance of the field: Nuclear factor kappa B (NF-κB) is activated by a variety of cancer-
promoting agents. The reciprocal activation between NF-κB and inflammatory cytokines …

Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis

HC Wang, W Huang, MD Lai, IJ Su - Cancer science, 2006 - Wiley Online Library
Although hepatitis B virus (HBV) has been documented to cause hepatocellular carcinoma
(HCC), the exact role of HBV in the development of HCC remains enigmatic. Several …

Molecular targets of luteolin in cancer

MJ Tuorkey - European Journal of Cancer Prevention, 2016 - journals.lww.com
Many food-derived phytochemical compounds and their derivatives represent a cornucopia
of new anticancer compounds. Despite extensive study of luteolin, the literature has no …

[PDF][PDF] NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target

W Chen, Z Li, L Bai, Y Lin - Front Biosci (Landmark Ed), 2011 - article.imrpress.com
Introduction 3. NF-kappaB activation pathways 3.1. Protein components in the NF-kappaB
family 3.2. The pathways leading to NF-kappaB activation 4. NF-kappaB's cellular functions …